These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38577532)

  • 21. Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The Gambia.
    Mahale P; Aka P; Chen X; Pfeiffer RM; Liu P; Groover S; Mendy M; Njie R; Goedert JJ; Kirk GD; Glenn JS; O'Brien TR
    J Viral Hepat; 2019 Jun; 26(6):738-749. PubMed ID: 30661282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative epidemiological study of hepatitis B and hepatitis D virus infections in Yanomami and Piaroa Amerindians of Amazonas State, Venezuela.
    Duarte MC; Cardona N; Poblete F; González K; García M; Pacheco M; Botto C; Pujol FH; Williams JR
    Trop Med Int Health; 2010 Aug; 15(8):924-33. PubMed ID: 20561309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
    Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program.
    Lin HH; Lee SS; Yu ML; Chang TT; Su CW; Hu BS; Chen YS; Huang CK; Lai CH; Lin JN; Wu JC
    Hepatology; 2015 Jun; 61(6):1870-9. PubMed ID: 25677884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and characteristics of hepatitis B and D virus infections among HIV-positive individuals in Southwestern Nigeria.
    Opaleye OO; Akanbi OA; Osundare FA; Wang B; Adesina O; Oluremi AS; Sunday ST; Akindele AA; Klink P; Bock CT
    Virol J; 2021 Jan; 18(1):20. PubMed ID: 33446224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of hepatitis delta virus among people with hepatitis B virus and HIV coinfection in Botswana.
    Baruti K; Phinius BB; Phakedi B; Mpebe G; Choga W; Bhebhe L; Mulenga G; Moraka NO; Ratsoma T; Pretorius-Holme M; Makhema J; Shapiro R; Lockman S; Moyo S; Jongman M; Anderson M; Gaseitsiwe S
    J Infect Public Health; 2023 Nov; 16(11):1736-1741. PubMed ID: 37734129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High prevalence and significance of hepatitis D virus infection among treatment-naïve HBsAg-positive patients in Northern Vietnam.
    Sy BT; Ratsch BA; Toan NL; Song le H; Wollboldt C; Bryniok A; Nguyen HM; Luong HV; Velavan TP; Wedemeyer H; Kremsner PG; Bock CT
    PLoS One; 2013; 8(10):e78094. PubMed ID: 24205106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis delta in HIV-infected individuals in Europe.
    Soriano V; Grint D; d'Arminio Monforte A; Horban A; Leen C; Poveda E; Antunes F; de Wit S; Lundgren J; Rockstroh J; Peters L
    AIDS; 2011 Oct; 25(16):1987-92. PubMed ID: 21857493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular epidemiology of hepatitis D virus circulating in Southwestern Nigeria.
    Opaleye OO; Japhet OM; Adewumi OM; Omoruyi EC; Akanbi OA; Oluremi AS; Wang B; Tong Hv; Velavan TP; Bock CT
    Virol J; 2016 Apr; 13():61. PubMed ID: 27044424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Epidemiology of Hepatitis D Virus in North Africa: A Systematic Review and Meta-Analysis.
    Daw MA; Daw AM; Sifennasr NEM; Draha AM; Daw AM; Daw AM; Ahmed MO; Mokhtar ES; El-Bouzedi A; Daw IM
    ScientificWorldJournal; 2018; 2018():9312650. PubMed ID: 30356409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis D virus and hepatitis B virus infection in Amerindian communities of the Amazonas state, Colombia.
    di Filippo Villa D; Cortes-Mancera F; Payares E; Montes N; de la Hoz F; Arbelaez MP; Correa G; Navas MC
    Virol J; 2015 Oct; 12():172. PubMed ID: 26497287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter study of viral hepatitis in a United States hemophilic population.
    Troisi CL; Hollinger FB; Hoots WK; Contant C; Gill J; Ragni M; Parmley R; Sexauer C; Gomperts E; Buchanan G
    Blood; 1993 Jan; 81(2):412-8. PubMed ID: 7678517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis D outbreak among children in a hepatitis B hyper-endemic settlement in Greenland.
    Børresen ML; Olsen OR; Ladefoged K; McMahon BJ; Hjuler T; Panum I; Simonetti J; Jones C; Krarup H; Koch A
    J Viral Hepat; 2010 Mar; 17(3):162-70. PubMed ID: 19780937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrating viral hepatitis management into the emergency department: A further step towards viral hepatitis elimination.
    Llaneras J; Ruiz-Cobo JC; Rando-Segura A; Barreira-Díaz A; Domínguez-Hernández R; Rodríguez-Frías F; Campins M; Colom J; Casado MA; Blanco-Grau A; Bañares J; Monforte A; Falcó-Roget A; Ruíz L; Meza B; Pumarola T; Riveiro-Barciela M; Esteban R; Buti M
    JHEP Rep; 2024 Jan; 6(1):100932. PubMed ID: 38074506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort.
    d'Arminio Monforte A; Tavelli A; Salpini R; Piermatteo L; D'Anna S; Carrara S; Malagnino V; Mazzotta V; Brancaccio G; Marchetti GC; Rosselli Del Turco E; Rossotti R; Mussini C; Antinori A; Lo Caputo S; Ceccherini Silberstein F; Gaeta GB; Svicher V; Puoti M;
    Liver Int; 2024 Feb; 44(2):603-613. PubMed ID: 38100128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High endemicity and low molecular diversity of hepatitis B virus infections in pregnant women in a rural district of North Cameroon.
    Ducancelle A; Abgueguen P; Birguel J; Mansour W; Pivert A; Le Guillou-Guillemette H; Sobnangou JJ; Rameau A; Huraux JM; Lunel-Fabiani F
    PLoS One; 2013; 8(11):e80346. PubMed ID: 24265811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delta hepatitis within the Veterans Affairs medical system in the United States: Prevalence, risk factors, and outcomes.
    Kushner T; Serper M; Kaplan DE
    J Hepatol; 2015 Sep; 63(3):586-92. PubMed ID: 25962883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets.
    Colagrossi L; Salpini R; Scutari R; Carioti L; Battisti A; Piermatteo L; Bertoli A; Fabeni L; Minichini C; Trimoulet P; Fleury H; Nebuloso E; De Cristofaro M; Cappiello G; Spanò A; Malagnino V; Mari T; Barlattani A; Iapadre N; Lichtner M; Mastroianni C; Lenci I; Pasquazzi C; De Sanctis GM; Galeota Lanza A; Stanzione M; Stornaiuolo G; Marignani M; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Perno CF; Coppola N; Svicher V
    Viruses; 2018 Jul; 10(7):. PubMed ID: 29987240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.